Abstract:Although the use of bioresorbable materials in stent production is thought to improve long-term safety compared to their durable counterparts, a recent FDA report on the 2-year follow-up of the first FDA-approved bioresorbable vascular stent showed an increased occurrence of major adverse cardiac events and thrombosis in comparison to the metallic control. In order to overcome the issues of first generation bioresorbable polymers, a series of polyethylene glycol-functionalized poly-L-lactide-co-ε-caprolactone copolymers with varying lactide-to-caprolactone content is developed using a novel one-step PEG-functionalization and copolymerization strategy. This approach represents a new facile way toward surface enhancement for cellular interaction, which is shown by screening these materials regarding their cyto- and hemocompatibility in terms of cytotoxicity, hemolysis, platelet adhesion, leucocyte activation and endothelial cell adhesion. By varying the lactide-to-caprolactone polymer composition, it is possible to gradually affect endothelial and platelet adhesion which allows fine-tuning of the biological response based on polymer chemistry. All polymers developed were non-cytotoxic, had acceptable leucocyte activation levels and presented non-hemolytic (<2% hemolysis rate) behavior except for PLCL-PEG 55:45 which presented hemolysis rate of 2.5% ± 0.5. Water contact angles were reduced in the polymers containing PEG functionalization (PLLA-PEG: 69.8° ± 2.3, PCL-PEG: 61.2° ± 7.5) versus those without (PLLA: 79.5° ± 3.2, PCL: 76.4° ± 10.2) while the materials PCL-PEG550, PLCL-PEG550 90:10 and PLCL-PEG550 70:30 demonstrated best endothelial cell adhesion. PLLA-PEG550 and PLCL-PEG550 70:30 presented as best candidates for cardiovascular implant use from a cytocompatibility perspective across the spectrum of testing completed. Altogether, these polymers are excellent innovative materials suited for an application in stent manufacture due to the ease in translation of this one-step synthesis strategy to device production and their excellent in vitro cyto- and hemocompatibility.

Biological evaluation of Fe₃O₄-poly(L-lactide)-poly(ethylene glycol)-poly(L-lactide) magnetic microspheres prepared in supercritical CO₂.

Study of Fe 3 O 4 –PLLA–PEG–PLLA magnetic microspheres based on supercritical CO 2 : Preparation, physicochemical characterization, and drug loading investigation

Comparaison De L’efficacité De Une Versus Deux Iiu Dans Les Infertilités Idiopathiques Ou Avec Facteurs Masculins : Étude Prospective Randomisée En Cycle Hyperstimulé

Preparation of microspheres of superoxide dismutase and their activities

Preparation of biodegradable magnetic microspheres with poly(lactic acid)-coated magnetite

Nanomagnetite-embedded PLGA Spheres for Multipurpose Medical Applications

Biodegradable Magnesium-Incorporated Poly(L-lactic Acid) Microspheres for Manipulation of Drug Release and Alleviation of Inflammatory Response

Electrospun Magnetic Poly(l-Lactide) (PLLA) Nanofibers by Incorporating PLLA-stabilized Fe3O4 Nanoparticles.

Cytocompatibility Evaluation of a Novel Series of PEG-Functionalized Lactide-Caprolactone Copolymer Biomaterials for Cardiovascular Applications

Biocompatible Polysiloxane-Containing Diblock Copolymer Peo-B-P Gamma Mps for Coating Magnetic Nanoparticles

Preparation and in vitro evaluation of PEG-coated superparamagnetic iron oxide nanoparticles

Formation of methotrexate-PLLA-PEG-PLLA composite microspheres by microencapsulation through a process of suspension-enhanced dispersion by supercritical CO2.

Magnetic PLGA microspheres loaded with SPIONs promoted the reconstruction of bone defects through regulating the bone mesenchymal stem cells under an external magnetic field

Study of Lysozyme‐polymer Composite Microparticles in Supercritical CO2

Magnetite Nanoparticles Coated with PEG 3350-Tween 80: In Vitro Characterization Using Primary Cell Cultures

Fabrication of Magnetic Poly(L-lactide) (PLLA)/Fe3O4 Composite Electrospun Fibers

Solvent-free Atom Transfer Radical Polymerization for the Preparation of Poly(poly(ethyleneglycol) Monomethacrylate)-Grafted Fe3O4 Nanoparticles: Synthesis, Characterization and Cellular Uptake.

In vitro biocompatibility of magnetic thermo-responsive nanohydrogel particles of poly(N-isopropylacrylamide-co-acrylic acid) with Fe3O4 cores: effect of particle size and chemical composition

Fe3O4@poly(2-hydroxyethyl methacrylate)-graft-poly(ε}-caprolactone) magnetic nanoparticles with branched brush polymeric shell

Optimization and characterization of chemically modified polymer microspheres and their effect on cell behavior

Fe3O4@poly(2-hydroxyethyl methacrylate)-graft-poly(ɛ-caprolactone) magnetic nanoparticles with branched brush polymeric shell